ABSTRACT

While the existing literature has focused predominantly on how firms can benefit from collaborations with academic institutions such as universities and research institutions, this study explores whether the proportion of (formal) collaborations with different types of firm partners in strategic R&D alliances is associated with publications originating in academic institutions. The empirical analysis is based on a unique dataset of publications in pharmaceutical cancer research. The results suggest that the share of collaborations with industry partners has an inverted u-shaped relationship with the reputation of the journal in which an article originating in an academic institution is published. The share of alliances with pharmaceutical firms shows a similar inverted u-shaped pattern, suggesting that research originating in academic institutions can only benefit from alliances with pharmaceutical firms through resource inflows up to a threshold.

摘要

虽然现有文献主要集中于公司如何从与大学和研究机构等学术机构的合作中受益，但本研究探讨了在战略研发联盟中与不同类型的公司合作伙伴进行（正式）合作的比例是否与原始出版物相关在学术机构。实证分析基于药物癌症研究中出版物的唯一数据集。结果表明，与行业合作伙伴的合作份额与期刊的声誉呈倒U型关系，在该期刊中发表了来自学术机构的文章。与制药公司结盟的份额显示出类似的倒U形图案，